HTX-011 Receives Breakthrough Therapy Designation from FDA for Postoperative Pain Management
June 22nd 2018This is the only long-acting local anesthetic to demonstrate significantly reduced postoperative pain and opioid use through 72 hours compared to bupivacaine solution for postoperative pain management.
Read More